Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
213
-
Total 13F shares, excl. options
-
50,545,295
-
Shares change
-
+1,543,492
-
Total reported value, excl. options
-
$1,200,362,920
-
Value change
-
+$48,582,918
-
Put/Call ratio
-
36%
-
Number of buys
-
120
-
Number of sells
-
-88
-
Price
-
$23.75
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2020
245 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2020.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 213 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,545,295 shares
of 56,047,431 outstanding shares and own 90% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,904,300 shares), VANGUARD GROUP INC (5,422,018 shares), ARMISTICE CAPITAL, LLC (2,208,000 shares), DIMENSIONAL FUND ADVISORS LP (1,960,011 shares), MACQUARIE GROUP LTD (1,871,954 shares), STATE STREET CORP (1,838,873 shares), RENAISSANCE TECHNOLOGIES LLC (1,592,800 shares), Aristotle Capital Boston, LLC (1,027,838 shares), FULLER & THALER ASSET MANAGEMENT, INC. (956,924 shares), and RICE HALL JAMES & ASSOCIATES, LLC (925,486 shares).
This table shows the top 213 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.